Leading Nk Cell Therapy Company for Advanced Treatment

Beijing BIOOCUS Biotech Ltd. is a leading Nk cell therapy company that specializes in developing innovative therapies for cancer and other diseases. Our flagship product, NKcell-CD16, harnesses the power of natural killer (NK) cells to target and kill cancer cells, providing a promising new avenue for cancer treatment, NKcell-CD16 is a cutting-edge immunotherapy that is engineered to enhance the anti-tumor activity of NK cells. By targeting the CD16 receptor, NKcell-CD16 is able to effectively recognize and destroy cancer cells, while sparing healthy tissues. This targeted approach minimizes the side effects often associated with traditional cancer treatments, offering a more gentle and personalized treatment option for patients, Our Nk cell therapy has shown promising results in preclinical and clinical studies, demonstrating its potential as a transformative treatment for various types of cancer. With a commitment to advancing the field of Nk cell therapy, Beijing BIOOCUS Biotech Ltd. is dedicated to bringing innovative and effective treatments to patients in need